Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
423
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Beta Bionics Inc. market cap is $800.28M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Beta Bionics Inc. 52 week high is $32.71 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Beta Bionics Inc. 52 week low is $8.80 as of November 18, 2026.
Beta Bionics Inc. stock price today is $14.33.
Beta Bionics Inc. stock price yesterday was $14.72.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Beta Bionics Inc.'s P/E ratio is -7.97.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Beta Bionics Inc. P/B ratio is 1.9937.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Beta Bionics Inc. 50-day moving average is $18.29.